News - MedTech & Diagnostics
Stryker launches limited-release medical bed to support critical needs during COVID-19 pandemic

MedTech News: Stryker has developed a low-cost, limited-release emergency response bed to quickly aid healthcare providers with efficient care during the COVID-19 pandemic.
Stryker anticipates producing 10,000 beds a week to meet increased needs.
Stryker’s Emergency Relief Bed is a low-cost, readily available solution intended to serve those on the front lines – ranging from hospital emergency departments to triage and pop-up areas of care. It includes a six-inch-thick foam surface.
The Emergency Relief Bed features a 30-degree head of bed angle to accommodate patients in respiratory distress, including ventilated patients. It also features low height and an attached IV pole.
“People are at the heart of what we do, and COVID-19 hasn’t changed that. It has amplified our mission of making healthcare better. We’re focused on meeting the supply needs of our customers so they can focus on taking care of patients right now. That’s why we raced to develop our Emergency Relief Bed, which will help emergency responders and caregivers move and position patients efficiently during this critical time,” said Brad Saar, president of Stryker’s Medical division.
The bed is intended for use in the COVID-19 pandemic to support increased patient numbers in healthcare facilities. Stryker is actively pursuing making the bed available in select markets around the world.
News - Pharmaceuticals
New vaccine guidelines risk further decline in immunisation
The intensifying political and public scrutiny of Dr Anthony Fauci has become emblematic of a wider struggle over trust in […]
MoreNews - Pharmaceuticals
The weight of the wait: GLP-1 boom hits PBS roadblock
More than one million Australians have been dispensed a GLP-1 receptor agonist over the past five years, accelerating the emergence […]
MoreNews - MedTech & Diagnostics
As insurer blame game escalates, patients miss out on the promise of private health
The Age and Sydney Morning Herald’s investigation into the Prescribed List (PL) and the pricing of medical devices has drawn […]
MoreLeadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
More